A landmark analysis design featuring the IMS Pharmetrics database was performed. This methods overview includes the assessment of: (1) exposure to prescription anticoagulants, antiplatelets, NSAIDs, and (2) outcomes including any bleeding or portal hypertension decompensation events. GI indicates gastrointestinal; HTN, hypertension; NSAID, nonsteroidal anti-inflammatory drug.